Lawrence J. Knopf

Lawrence J. Knopf discloses dealings in 2 companies, chiefly HeartWare International, Inc. and SQZ Biotechnologies Co. We count 46 filings; the first trade dates from 28 March 2012 and the latest from 30 June 2022.

Sales make up the whole of the open-market record (28 sales, €1.2M). The rest of the record consists of 2 share grants and 15 option exercises.

Most recently, on 5 July 2022, the filings show a share grant worth €3,828 in SQZ Biotechnologies Co. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.